Lilly’s Alzheimer’s super drug to be approved ‘any day’
LONDON: The pharma giant behind breakthrough Alzheimer’s drug Donanemab expects approval to come from US…
FEATURED
New drug hope for ‘childhood Alzheimer’s’ after global trials
Charity now set to build new pods for homeless people
Pensioner with ‘severe dementia’ living in care home is prosecuted
Inquest begins after man took wife’s end-of-life medication
Surveys show public support on euthanasia for mentally ill
Innovative Parkinson’s Project tries to solve the disease puzzle
INNOVATION
